$ASND Analysis and Prediction for Ascendis Pharma A/SChart Overview:
Instrument: Ascendis Pharma A/S (ASND)
Timeframe: 1-Hour Chart
Key Features:
Dark Pool Level: Highlighted at $140 (critical resistance).
Pivot Resistance: R1 ($141.91) as a significant resistance level.
Support Levels: S1 ($130.43), MY TGT ($127.07), and S2 ($124.47).
Trendlines:
Green ascending trendline providing support.
Price approaching a wedge structure, tightening between resistance and support.
Volume: Recent increases in volume, particularly on dips, indicate potential accumulation.
Key Observations:
Resistance at $140 and $141.91:
The price has faced multiple rejections around the $140-$141.91 zone, forming a strong resistance.
These rejections are marked by lower highs, signaling seller strength at these levels.
Support at $135.85 and $130.43:
The $135.85 pivot level aligns with the ascending green trendline, acting as immediate support.
A breakdown below this level could lead to a move toward $130.43 (S1 support), followed by $127.07.
Ascending Wedge:
The price is tightening within an ascending wedge pattern, with the upper bound at $140 and the lower bound following the green trendline.
This setup suggests an imminent breakout or breakdown.
Volume Analysis:
Increasing volume on support bounces shows potential buyer interest.
However, lack of volume during rallies toward resistance ($140) indicates hesitation to push higher.
Trading Scenarios:
Scenario 1: Bullish Breakout:
Entry:
Go long above $140 with confirmation (strong candle close above resistance and increased volume).
Targets:
Target 1: $141.91 (R1 resistance).
Target 2: $144-$145 (psychological resistance and potential Fibonacci extension).
Stop Loss:
Below $135.85, invalidating the breakout.
Scenario 2: Bearish Breakdown:
Entry:
Go short below $135.85, confirmed by a breakdown of the ascending green trendline and volume spike.
Targets:
Target 1: $130.43 (S1 support).
Target 2: $127.07 (MY TGT and stronger support zone).
Target 3: $124.47 (S2 support).
Stop Loss:
Above $140, invalidating the bearish thesis.
Risk Management:
Use a 1:3 risk-to-reward ratio to ensure profitable trades.
Adjust position sizes according to individual risk tolerance.
Volume Consideration:
A volume spike at key levels (breakout above $140 or breakdown below $135.85) will validate directional moves.
Weak volume during consolidation increases the likelihood of a false breakout or breakdown.
Summary:
The current chart setup for ASND suggests a critical decision point. The ascending wedge pattern indicates tightening price action, with resistance at $140-$141.91 and support around $135.85-$130.43. A breakout or breakdown from this zone will determine the next significant move. Traders should monitor volume and price action closely for confirmation.
A1SN34 trade ideas
ASND Stock-Weekly 26 EMA pointing upwards.
-Price on a previous key level that was test many times.
Long positions preferred.
-15 minute sideways movement with a shakeout forming a reverse head and shoulders pattern with a bullish breakout.
-Price entering the range after the breakout forming a MACD divergence.
Entry after the bullish movement that come after this pullback.
Stop loss below the 0.236 fibonacci price.
Target in the middle of the opposite negotiation area that happens to be just on the 1.618 fibonacci price.
ASND Ascendis Pharma A/S Options Ahead of EarningsAnalyzing the options chain and the chart patterns of ASND Ascendis Pharma A/S prior to the earnings report this week,
I would consider purchasing the 100usd strike price Calls with
an expiration date of 2023-9-15,
for a premium of approximately $6.45.
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
Looking forward to read your opinion about it.
ASND ( NASDAQ BIOTECH) rises on earnings and FDA submissionNASDAQ:ASND
as can be seen on the hourly chart ASND is in an uptrend
recent earnings were a good beat,
RSI is quite high and it is at one than one STD above
the multi-session VWAP.
ASND is on watch for a pullback to find an entry
as it has high upside.
$ASND can rise in the next daysContextual immersion trading strategy idea.
The demand for shares of Ascendis Pharma A/S looks higher than the supply.
This and other conditions can cause a rise in the share price in the next days.
So I opened a long position from $117,86;
stip-loss — $114,88
Information about take-profits will be later.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
ASCENDIS PHARMA ON THE CLIFF EDGEKEEP ALERTS SET FOR A BREAK OF $105, WHICH COULD RESULT IN A VERY NASTY FALL BACK DOWN TO THE GAP UP LEVEL $75,
AVERAGE ANALYSTS ESTIMATE $162.20
AVERAGE ANALYSTS RECOMMENDATION BUY
COMPANY PROFILE
Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. Through its TransCon technology, it develops a pipeline of sustained release prodrug therapies including endocrinology product candidates to support the market. The company was founded by Jan Moller Mikkelsen and Harald Rau in September 2006 and is headquartered in Hellerup, Denmark.
Strong uptrend for this stock, with candlesticks over kumo H1I have not identified potential key levels but this stock might be interesting to invest on.
If you follow my ideas, don't forget money management, and don't stay too long on any market as this is important to avoid a long time risk exposure.